DRI Healthcare Trust acquires royalty stake in cataract drug Omidria

DRI Healthcare Trust is wholly owned subsidiary of DRI Capital, a Canadian healthcare royalty private equity manager.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this